Invicta Diagnostic and Ravelcare IPOs Debut Strongly

Two companies, Invicta Diagnostic and Ravelcare, recently listed their shares on the stock market.

Invicta Diagnostic, which offers medical testing services, started trading at ₹100, which is 17.65% higher than its initial price of ₹85.

Ravelcare, a beauty and personal care brand, started trading at ₹201, which is 54.62% higher than its initial price of ₹130.

Both companies raised money through these listings to expand their businesses.

Invicta Diagnostic plans to open new medical centers, while Ravelcare wants to improve its marketing and open a new factory.

Many investors were interested in these listings, with Ravelcare receiving a very high number of bids.